select trial semaglutide cardiovascular outcomes non-diabetic 2023

select trial semaglutide cardiovascular outcomes non-diabetic 2023 of and tirzepatide for patients with type 2 diabetes in clinical practice VisualAbstract: Semaglutide and Cardiovascular Outcomes

Name: select trial semaglutide cardiovascular outcomes non-diabetic 2023 of and tirzepatide for patients with type 2 diabetes in clinical practice VisualAbstract: Semaglutide and Cardiovascular Outcomes
Brand: www.cmvroncone.com
SKU: 9640861640
Price: 28.25 USD
Availability: InStock
Rating: 4.2799000000000005 (5 reviews)

SKU: 9640861640

4.3

USD28.25 USD64.25

Pay in 4 interest-free payments of $7.06 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 16 - Aug 21

Description

doi: 10.1016/S2213-8587(20)30075-9 47 FriasJPBonoraENevarez RuizLLiYGYuZMilicevicZet al

On the basis of these findings, the overall efficacy and safety of tirzepatide has been investigated in the SURPASS clinical trial programme in comparison with placebo and other glucose-lowering medications including GLP-1 RAs and basal insulin [11]